Efficacy of statins in combination with interferon therapy in multiple sclerosis: a meta-analysis

Authors
Category Structured summary of systematic reviews
JournalDatabase of Abstracts of Reviews of Effects (DARE)
Year 2012
CRD SUMMARY: The authors concluded that the addition of statins to interferon therapy did not significantly influence disease progression, the relapse risk, or the Expanded Disability Status Scale scores of patients with relapse-remitting multiple sclerosis. This appears to have been a well-conducted review, but methodological and clinical differences between the trials mean that the reliability of the conclusions is uncertain.
Epistemonikos ID: b70b18a2d693ede51c3bfb9aac54f028ea1484f1
First added on: Jan 13, 2015